The News Review:
- Minorities are needed in clinical research
- Exenatide Clinical Data Analysis Shows No Increased Risk of …
- Lawmakers Detail Medical Research Sting: Company Was a Real Dog
- Circumcision reduces some infections
- Cardium Reports on Recent Highlights Financial Results and 2009 …
Minorities are needed in clinical research
Rochester Democrat and Chronicle
At some point new knowledge needs to be translated to people and tested in the real world. This requires that volunteers (either healthy individuals or people with the disease or condition that is being studied) step forward and agree to participate in medical research. This research commonly referred to as clinical research can take many forms such as evaluating the safety of a new drug comparing which of two existing treatments is more effective or examining the connection between health behaviors (e. diet and exercise) and certain diseases. Underrepresentation of population groups in health research hampers our ability to develop new ways to understand and treat diseases. We know that disease prevalence varies by population group.
Exenatide Clinical Data Analysis Shows No Increased Risk of …
FXBusiness
This finding suggests there is no increased risk of exenatide on cardiovascular outcomes and will be used to support the cardiovascular safety of exenatide once weekly a phase 3 investigational formulation of exenatide the active ingredient in BYETTA. To determine if there are favorable cardiovascular effects of exenatide treatment Lilly and Amylin intend to initiate a large cardiovascular outcomes trial with a superiority design that will evaluate the effects of exenatide once weekly on major cardiovascular events compared to standard of care with traditional antidiabetes medications. The global study will be sponsored by Amylin and Lilly and active discussions are ongoing to have the study led by two academic research centers The Diabetes Trial Unit at the xford Centre for Diabetes (xford England) and Duke Clinical Research Institute at Duke University (Durham N. The steering committee for this study is chaired by Professor Rury Holman FRCP director Diabetes Trial Unit xford University and Robert M.
Related from Zxyangchen: Mar 12′”Chinese rights leader’s family ‘defects to US’
Lawmakers Detail Medical Research Sting: Company Was a Real Dog
Wall Street Journal Blogs
A congressional committee’s sting operation into medical research – one that included a fake company with a fake surgical adhesive to be used in a fake clinical trial – was detailed this morning at a House Energy and Commerce Committee hearing. The hearing focused on the need for more oversight by and of institutional review boards empowered by regulators to decide whether planned clinical research involving humans should be allowed to go ahead. The tale of the surgical adhesive has already been aired in a news release by the IRB in question — Coast IRB of Colorado — which approved the clinical trial five months before learning that the company. Both were created as part of the House committee’s.
Circumcision reduces some infections
WWLP 22News
write(ads[tile]); Circumcision reduces some infections Circumcision trims risk of genital herpes and HPV Updated: Saturday 28 Mar 2009 9:25 PM EDTPublished : Saturday 28 Mar 2009 9:21 PM EDT – Heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted infections ? herpes simplex virus type 2 (HSV-2) the cause of genital herpes and human papillomavirus (HPV) which can cause cancer and genital warts according to a report in the March 26 issue of the New England Journal of Medicine (NEJM). In the study circumcision had no effect on their risk of becoming infected with the bacterium that causes syphilis however. The findings build upon earlier clinical research funded by the National Institute of Allergy and Infectious Disease (NIAID) part of the NIH which found that circumcision decreases a man?s risk of acquiring HIV infection through heterosexual intercourse by more than 50 percent. “Medically supervised adult male circumcision is a scientifically proven method for reducing a man?s risk of acquiring HIV infection through heterosexual intercourse” says NIAID Director Anthony S. “This new research provides compelling evidence that circumcision can provide some protection against genital herpes and human papillomavirus infections as well.
Cardium Reports on Recent Highlights Financial Results and 2009 …
FXBusiness
Consistent with Cardium’s business strategy the Company believes that InnerCool has reached a significant valuation inflection point within Cardium’s investment portfolio and with the appropriate strategic positioning best-in-class products and a pipeline of innovative product opportunities Cardium intends to advance InnerCool’s therapeutic cooling and warming products into corresponding markets through the strategic sale of the business to a large and diversified medical device company or through various vertical partnering opportunities with established companies having existing sales and marketing organizations but with a continuing need for innovative high-value content products. The Company believes this strategy is more cost-effective than building InnerCool into a fully integrated manufacturing sales and marketing organization. Recent highlights and ongoing product development and clinical research activities at InnerCool include the following: — U. Food and Drug Administration (FDA) 510(k) clearance to market the RapidBlue(TM) System an endovascular temperature modulation device. The new RapidBlue System is believed to be the most powerful easy to use endovascular-based system available. InnerCool has obtained CE mark approval and Underwriters Laboratories Inc.
